'The company has lost 65% of its market capitalisation in 10 months.'
Management must accept responsibility for this shocking result.
Alhambra.
Aren't statistics wonderful? Especially since you've picked the all-time high to compare losses against.
So I'll counter your argument by stating the following:
'The company has increased its market capitalisation by 191% in 17 months.'
Shareholders should applaud this amazing result and look forward to future FDA approvals and successful trials across many fronts.
Australian Newspaper MSB trial failure, page-164
-
- There are more pages in this discussion • 92 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.13 |
Change
-0.055(4.66%) |
Mkt cap ! $1.284B | |||
| Open | High | Low | Value | Volume |
| $1.18 | $1.18 | $1.13 | $4.824M | 4.236M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 25589 | $1.13 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.13 | 10000 | 1 |
View Market Depth
| Last trade - 16.10pm 17/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |